Female Alms1-deficient mice develop echocardiographic features of adult but not infantile Alström syndrome cardiomyopathy
- PMID: 38756069
- PMCID: PMC11225586
- DOI: 10.1242/dmm.050561
Female Alms1-deficient mice develop echocardiographic features of adult but not infantile Alström syndrome cardiomyopathy
Abstract
Alström syndrome (AS), a multisystem disorder caused by biallelic ALMS1 mutations, features major early morbidity and mortality due to cardiac complications. The latter are biphasic, including infantile dilated cardiomyopathy and distinct adult-onset cardiomyopathy, and poorly understood. We assessed cardiac function of Alms1 knockout (KO) mice by echocardiography. Cardiac function was unaltered in Alms1 global KO mice of both sexes at postnatal day 15 (P15) and 8 weeks. At 23 weeks, female - but not male - KO mice showed increased left atrial area and decreased isovolumic relaxation time, consistent with early restrictive cardiomyopathy, as well as reduced ejection fraction. No histological or transcriptional changes were seen in myocardium of 23-week-old female Alms1 global KO mice. Female mice with Pdgfra-Cre-driven Alms1 deletion in cardiac fibroblasts and in a small proportion of cardiomyocytes did not recapitulate the phenotype of global KO at 23 weeks. In conclusion, only female Alms1-deficient adult mice show echocardiographic evidence of cardiac dysfunction, consistent with the cardiomyopathy of AS. The explanation for sexual dimorphism remains unclear but might involve metabolic or endocrine differences between sexes.
Keywords: ALMS1; Alstrom syndrome; Alström syndrome; Cardiomyopathy; Ciliopathy; Heart; Primary cilia.
© 2024. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interests R.K.S. has received consulting fees from Novartis, Astra Zeneca and Alnylam, research contribution in kind from Pfizer, and speaking fees from Novo Nordisk, Eli Lilly and Amryt.
Figures




Similar articles
-
Characterisation of infantile cardiomyopathy in Alström syndrome using ALMS1 knockout induced pluripotent stem cell derived cardiomyocyte model.Mol Genet Metab. 2024 Sep-Oct;143(1-2):108575. doi: 10.1016/j.ymgme.2024.108575. Epub 2024 Sep 2. Mol Genet Metab. 2024. PMID: 39243575
-
Recessive ciliopathy mutations in primary endocardial fibroelastosis: a rare neonatal cardiomyopathy in a case of Alstrom syndrome.J Mol Med (Berl). 2021 Nov;99(11):1623-1638. doi: 10.1007/s00109-021-02112-z. Epub 2021 Aug 13. J Mol Med (Berl). 2021. PMID: 34387706 Free PMC article.
-
Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alström syndrome.Mol Metab. 2024 Jun;84:101933. doi: 10.1016/j.molmet.2024.101933. Epub 2024 Apr 6. Mol Metab. 2024. PMID: 38583571 Free PMC article.
-
Mutation identification and prediction for severe cardiomyopathy in Alström syndrome, and review of the literature for cardiomyopathy.Orphanet J Rare Dis. 2022 Sep 15;17(1):359. doi: 10.1186/s13023-022-02483-7. Orphanet J Rare Dis. 2022. PMID: 36109815 Free PMC article. Review.
-
The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey.J Hum Genet. 2015 Jan;60(1):1-9. doi: 10.1038/jhg.2014.85. Epub 2014 Oct 9. J Hum Genet. 2015. PMID: 25296579 Free PMC article. Review.
Cited by
-
Translating multiscale research in rare disease.Dis Model Mech. 2024 Jun 1;17(6):dmm052009. doi: 10.1242/dmm.052009. Epub 2024 Jul 10. Dis Model Mech. 2024. PMID: 38982973 Free PMC article.
References
-
- Arsov, T., Silva, D. G., O'Bryan, M. K., Sainsbury, A., Lee, N. J., Kennedy, C., Manji, S. S. M., Nelms, K., Liu, C., Vinuesa, C. G.et al. (2006b). Fat aussie - a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol. Endocrinol. 20, 1610-1622. 10.1210/me.2005-0494 - DOI - PubMed
-
- Baig, S., Veeranna, V., Bolton, S., Edwards, N., Tomlinson, J. W., Manolopoulos, K., Moran, J., Steeds, R. P. and Geberhiwot, T. (2018). Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. BMC Endocr. Disord. 18, 88. 10.1186/s12902-018-0315-6 - DOI - PMC - PubMed
-
- Baig, S., Dowd, R., Edwards, N. C., Hodson, J., Fabritz, L., Vijapurapu, R., Liu, B., Geberhiwot, T. and Steeds, R. P. (2020b). Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis. Orphanet J. Rare Dis. 15, 139. 10.1186/s13023-020-01426-4 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous